Parnax Lab Limited (BOM:506128)
India · Delayed Price · Currency is INR 125.50
+7.00 (5.91%)
At close: Feb 12, 2026
Parnax Lab Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 2,052 | 1,877 | 1,887 | 1,676 | 1,630 | 900.6 |
Other Revenue | 0.42 | 0.42 | 0.93 | - | - | 0.65 |
| 2,053 | 1,878 | 1,888 | 1,676 | 1,630 | 901.25 | |
Revenue Growth (YoY) | 4.77% | -0.54% | 12.65% | 2.81% | 80.89% | -5.67% |
Cost of Revenue | 1,182 | 1,001 | 1,066 | 934.34 | 937.93 | 447.92 |
Gross Profit | 870.45 | 876.98 | 822.5 | 741.73 | 692.38 | 453.34 |
Selling, General & Admin | 253.99 | 251.11 | 244.75 | 211.09 | 185.65 | 147.13 |
Other Operating Expenses | 351.02 | 356.98 | 340.28 | 298.62 | 275.62 | 205.09 |
Operating Expenses | 681.59 | 681.86 | 654.67 | 575 | 519.92 | 403.81 |
Operating Income | 188.86 | 195.12 | 167.82 | 166.73 | 172.46 | 49.53 |
Interest Expense | -49.81 | -52.38 | -52.62 | -48.97 | -51.69 | -49.82 |
Interest & Investment Income | 1.93 | 1.93 | 4.22 | 2.37 | 1.63 | 0.88 |
Currency Exchange Gain (Loss) | 0.63 | 0.63 | 0.47 | 3.73 | 0.82 | -0.54 |
Other Non Operating Income (Expenses) | 8.99 | 11.44 | -0.13 | -0.54 | -0.61 | -0.99 |
EBT Excluding Unusual Items | 150.6 | 156.74 | 119.76 | 123.32 | 122.61 | -0.94 |
Gain (Loss) on Sale of Investments | - | - | - | -0.64 | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.32 | 0.12 | 0.03 | 0.11 |
Other Unusual Items | - | - | 0.42 | - | - | - |
Pretax Income | 150.6 | 156.74 | 120.5 | 122.8 | 122.64 | -0.84 |
Income Tax Expense | 40.24 | 41.35 | 24.25 | 36.47 | 40.06 | 2.79 |
Earnings From Continuing Operations | 110.36 | 115.39 | 96.25 | 86.33 | 82.58 | -3.62 |
Minority Interest in Earnings | -0.08 | -0.2 | -0.16 | -0.15 | -0.15 | -0.02 |
Net Income | 110.28 | 115.19 | 96.09 | 86.18 | 82.43 | -3.64 |
Net Income to Common | 110.28 | 115.19 | 96.09 | 86.18 | 82.43 | -3.64 |
Net Income Growth | -6.59% | 19.87% | 11.50% | 4.55% | - | - |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 9 | 9 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 9 | 9 |
Shares Change (YoY) | -0.04% | - | 3.76% | 30.04% | 0.08% | - |
EPS (Basic) | 9.60 | 10.03 | 8.37 | 7.79 | 9.68 | -0.43 |
EPS (Diluted) | 9.60 | 10.03 | 8.37 | 7.79 | 9.68 | -0.43 |
EPS Growth | -6.56% | 19.87% | 7.46% | -19.60% | - | - |
Free Cash Flow | -68 | 137.24 | -165.38 | 96.3 | -92.82 | -2.31 |
Free Cash Flow Per Share | -5.92 | 11.95 | -14.40 | 8.70 | -10.90 | -0.27 |
Gross Margin | 42.40% | 46.70% | 43.56% | 44.25% | 42.47% | 50.30% |
Operating Margin | 9.20% | 10.39% | 8.89% | 9.95% | 10.58% | 5.50% |
Profit Margin | 5.37% | 6.13% | 5.09% | 5.14% | 5.06% | -0.40% |
Free Cash Flow Margin | -3.31% | 7.31% | -8.76% | 5.75% | -5.69% | -0.26% |
EBITDA | 253.47 | 256.93 | 227.75 | 225.22 | 227.81 | 99.3 |
EBITDA Margin | 12.35% | 13.68% | 12.06% | 13.44% | 13.97% | 11.02% |
D&A For EBITDA | 64.61 | 61.82 | 59.93 | 58.49 | 55.35 | 49.78 |
EBIT | 188.86 | 195.12 | 167.82 | 166.73 | 172.46 | 49.53 |
EBIT Margin | 9.20% | 10.39% | 8.89% | 9.95% | 10.58% | 5.50% |
Effective Tax Rate | 26.72% | 26.38% | 20.12% | 29.70% | 32.66% | - |
Revenue as Reported | 2,067 | 1,894 | 1,895 | 1,684 | 1,634 | 902.7 |
Advertising Expenses | - | 2.38 | 2.67 | 2.91 | 4.42 | 2.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.